Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,400 reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted October 09, 2014
New Synthetic Stimulant Found in Supplements
DMBA is an analogue of the pharmaceutical stimulant, 1,3-dimethylamylamine (DMAA), which was recently banned by the U.S. Food and Drug Administration. Supplements containing DMBA are marketed to improve athletic performance, increase weight loss and enhance brain function.
Authors of the recent report suggest that regulatory agencies should act expeditiously to warn consumers and remove DMBA from all dietary supplements. They note that 3 cases of adverse events have been reported in Europe with a supplement found to contain DMBA sold as "Unstoppable" by Dedicated. Symptoms reported by users were similar and included the feeling of rushing, difficulty sitting still, a sense of motion and increased focus, although it is not known if DMBA was responsible for the adverse effects.
The supplements recently found to contain DMBA in the U.S. are Contraband, Redline White Heat, Evol, Preamp by Hybrid, OxyphenRX AMP'D, OxyTHERM Pro, AMP Citrate, Oxyfit Xtreme, Synetherm, AMPitropin, Decimate Amplified, AMPilean, and Frenzy.
Join today to unlock all member benefits including full access to all recalls & warnings
Join NowAlready a member? Sign In Here.
Join now at www.consumerlab.com/join/
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
If you believe that a dietary supplement (e.g., vitamin, mineral, or herbal supplement) or other nutritional product has caused an unexpected, adverse reaction, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their Safety Reporting Portal at https://www.safetyreporting.hhs.gov.
Please complete the form below as accurately as possible. You may need to check the label on the product.
Thank you for submitting your report.
Generic Drug Problem Report
If you believe that a generic drug has not acted like the original drug, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their MedWatch program at the FDA MedWatch website.
Please complete the form below as accurately as possible. You may need to check the label on the drug.
Thank you for submitting your report.
